Synthesizing high-purity pharmaceuticals involve preparing reaction mixture including one pharmaceutical precursor, introducing advanced catalyst with precision-engineered active sites into reaction mixture, and performing catalytic reaction under controlled conditions
	DESAI K B; MODI S D
	2024-12-12
专利权人	DESAI K B (DESA-Individual) ; MODI S D (MODI-Individual)
申请日期	2024-12-12
专利号	IN202421098485-A
成果简介	NOVELTY - Synthesizing high-purity pharmaceuticals involve preparing a reaction mixture including one pharmaceutical precursor, introducing an advanced catalyst with precision-engineered active sites into the reaction mixture, performing a catalytic reaction under controlled conditions to produce a target pharmaceutical compound, and purifying the pharmaceutical compound to achieve a purity level compliant with regulatory standards USE - Method for synthesizing high-purity pharmaceuticals. ADVANTAGE - The method enhances reaction selectivity, minimizes by-products, achieves superior yield, ensures consistency and pharmaceutical-grade purity exceeding 99.9%, in cost-effective manner. DETAILED DESCRIPTION - An INDEPENDENT CLAIM is included for a catalytic process for pharmaceutical synthesis, which comprises: an active sites tailored for a specific reaction type selected from hydrogenation, C-C coupling, or heterocycle formation.
IPC 分类号	A61K-009/00 ; B01J-031/00
国家	印度
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/14126
专题	中国科学院新疆生态与地理研究所
作者单位	1.DESAI K B (DESA-Individual) 2.MODI S D (MODI-Individual)
推荐引用方式 GB/T 7714	DESAI K B,MODI S D. Synthesizing high-purity pharmaceuticals involve preparing reaction mixture including one pharmaceutical precursor, introducing advanced catalyst with precision-engineered active sites into reaction mixture, and performing catalytic reaction under controlled conditions. IN202421098485-A[P]. 2024.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。